1471-2466

BMC Pulmonary Medicine

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 3925 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact3925 DOIs
2

Add abstracts to 2447 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact2447 DOIs
3

Add license metadata to 357 records

License metadata tells indexers and readers how each article may be reused.

Low impact357 DOIs

DOIs for this ISSN

Showing the top 5 of 5098 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The frequency of asthma exacerbations and healthcare utiliza… (10.1186/s12890-017-0409-3)
Abstract ORCID License
179.19 244
2 Delay in diagnosis of pulmonary tuberculosis in low-and midd… (10.1186/s12890-017-0551-y)
Abstract ORCID License
174.01 208
3 Barriers to timely diagnosis of interstitial lung disease in… (10.1186/s12890-017-0560-x)
Abstract ORCID License
169.68 182
4 Pirfenidone attenuates bleomycin-induced pulmonary fibrosis… (10.1186/s12890-017-0405-7)
Abstract ORCID License
162.55 146
5 Risk factors for acute respiratory infections in children un… (10.1186/s12890-018-0579-7)
Abstract ORCID License
158.29 128
6 Identification of the lipid biomarkers from plasma in idiopa… (10.1186/s12890-017-0513-4)
Abstract ORCID License
151.59 104
7 Exploring efficacy and safety of oral Pirfenidone for progre… (10.1186/s12890-017-0462-y)
Abstract ORCID License
150.65 101
8 Breathlessness and presentation to the emergency department:… (10.1186/s12890-017-0396-4)
Abstract ORCID License
149.01 96
9 Seasonal influenza vaccination in patients with COPD: a syst… (10.1186/s12890-017-0420-8)
Abstract ORCID License
149.01 96
10 Qualitative European survey of patients with idiopathic pulm… (10.1186/s12890-016-0171-y)
Abstract ORCID License
147.98 93
11 Detailed analysis of sputum and systemic inflammation in ast… (10.1186/s12890-016-0208-2)
Abstract ORCID License
147.28 91
12 The care needs of patients with idiopathic pulmonary fibrosi… (10.1186/s12890-015-0145-5)
Abstract ORCID License
146.93 90
13 Unmet needs in the treatment of idiopathic pulmonary fibrosi… (10.1186/s12890-017-0468-5)
Abstract ORCID License
146.93 90
14 Salidroside attenuates hypoxia-induced pulmonary arterial sm… (10.1186/s12890-017-0477-4)
Abstract ORCID License
146.93 90
15 Electromagnetic navigation bronchoscopy to access lung lesio… (10.1186/s12890-017-0403-9)
Abstract ORCID License
145.46 86
16 The clinical features of respiratory infections caused by th… (10.1186/s12890-015-0128-6)
Abstract ORCID License
144.32 83
17 Clinical and economic burden of idiopathic pulmonary fibrosi… (10.1186/s12890-015-0165-1)
Abstract ORCID License
143.54 81
18 Serological and morphological prognostic factors in patients… (10.1186/s12890-017-0453-z)
Abstract ORCID License
141.91 77
19 Novel homozygous BMP9 nonsense mutation causes pulmonary art… (10.1186/s12890-016-0183-7)
Abstract ORCID License
141.49 76
20 Upregulation of interleukin-33 and thymic stromal lymphopoie… (10.1186/s12890-017-0380-z)
Abstract ORCID License
139.75 72
21 Survival in Idiopathic pulmonary fibrosis acute exacerbation… (10.1186/s12890-015-0146-4)
Abstract ORCID License
137.91 68
22 Change in forced vital capacity and associated subsequent ou… (10.1186/s12890-015-0161-5)
Abstract ORCID License
137.91 68
23 Baicalin attenuates bleomycin-induced pulmonary fibrosis via… (10.1186/s12890-016-0294-1)
Abstract ORCID License
136.96 66
24 Azithromycin for idiopathic acute exacerbation of idiopathic… (10.1186/s12890-017-0437-z)
Abstract ORCID License
136.96 66
25 Physician perspectives on the burden and management of asthm… (10.1186/s12890-017-0492-5)
Abstract ORCID License
134.95 62
26 A new clinical algorithm scoring for management of suspected… (10.1186/s12890-017-0406-6)
Abstract ORCID License
132.81 58
27 TLR4-NOX2 axis regulates the phagocytosis and killing of Myc… (10.1186/s12890-017-0517-0)
Abstract ORCID License
132.81 58
28 Periostin levels and eosinophilic inflammation in poorly-con… (10.1186/s12890-016-0230-4)
Abstract ORCID License
132.26 57
29 Effect of sivelestat sodium in patients with acute lung inju… (10.1186/s12890-017-0498-z)
Abstract ORCID License
132.26 57
30 Plasma surfactant protein-D as a diagnostic biomarker for ac… (10.1186/s12890-017-0532-1)
Abstract ORCID License
131.69 56
31 Association of physical activity with lung function in lung-… (10.1186/s12890-017-0562-8)
Abstract ORCID License
131.69 56
32 Interactive digital interventions to promote self-management… (10.1186/s12890-016-0248-7)
Abstract ORCID License
131.11 55
33 Association between Charlson comorbidity index score and out… (10.1186/s12890-017-0452-0)
Abstract ORCID License
131.11 55
34 Knowledge, attitudes and practices regarding tuberculosis ca… (10.1186/s12890-016-0344-8)
Abstract ORCID License
129.93 53
35 The pleural fluid lactate dehydrogenase/adenosine deaminase… (10.1186/s12890-017-0526-z)
Abstract ORCID License
129.93 53
36 Access to affordable medicines and diagnostic tests for asth… (10.1186/s12890-017-0527-y)
Abstract ORCID License
129.93 53
37 Attitudes and actions of asthma patients on regular maintena… (10.1186/1471-2466-6-13)
Abstract ORCID
129.39 386
38 Characteristics associated with progression in patients with… (10.1186/s12890-016-0349-3)
Abstract ORCID License
129.32 52
39 Nerve ablation after bronchial thermoplasty and sustained im… (10.1186/s12890-017-0554-8)
Abstract ORCID License
128.07 50
40 Mycobacteria infect different cell types in the human lung a… (10.1186/s12890-016-0185-5)
Abstract ORCID License
127.42 49
41 Lung functions among patients with pulmonary tuberculosis in… (10.1186/s12890-016-0213-5)
Abstract ORCID License
127.42 49
42 Obstructive sleep apnoea accelerates FEV1 decline in asthmat… (10.1186/s12890-017-0398-2)
Abstract ORCID License
127.42 49
43 From “traction bronchiectasis” to honeycombing in idiopathic… (10.1186/s12890-016-0245-x)
Abstract ORCID License
126.76 48
44 Cystic fibrosis lung environment and Pseudomonas aeruginosa… (10.1186/s12890-016-0339-5)
Abstract ORCID
126.51 338
45 Biodegradable polydioxanone stents in the treatment of adult… (10.1186/s12890-015-0160-6)
Abstract ORCID License
126.09 47
46 BreathDx – molecular analysis of exhaled breath as a diagnos… (10.1186/s12890-016-0353-7)
Abstract ORCID License
126.09 47
47 Long-term prognosis of chronic cough: a prospective, observa… (10.1186/s12890-017-0496-1)
Abstract ORCID License
126.09 47
48 Systematic review with meta-analysis of the epidemiological… (10.1186/1471-2466-11-36)
Abstract ORCID
125.26 319
49 Evaluating the interstitial lung disease multidisciplinary m… (10.1186/s12890-016-0179-3)
Abstract ORCID License
124.71 45
50 Propensity score analysis of lung cancer risk in a populatio… (10.1186/s12890-017-0465-8)
Abstract ORCID License
123.99 44